Literature DB >> 24354313

Predicting the antinociceptive efficacy of σ(1) receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor.

Maricel Gómez-Soler1, Víctor Fernández-Dueñas, Enrique Portillo-Salido, Pilar Pérez, Daniel Zamanillo, José Miguel Vela, Javier Burgueño, Francisco Ciruela.   

Abstract

We have developed a novel methodology for monitoring the σ1 receptor activation switch in living cells. Our assay uncovered the intrinsic nature of σ1 receptor ligands by recording the ligand-mediated conformational changes of this chaperone protein. The change triggered by each ligand correlated well with its ability to attenuate formalin induced nociception in an animal model of pain. This tool may assist in predicting the antinociceptive efficacy of σ1 receptor ligands.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24354313     DOI: 10.1021/jm401529t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Authors:  Hideaki Yano; Alessandro Bonifazi; Min Xu; Daryl A Guthrie; Stephanie N Schneck; Ara M Abramyan; Andrew D Fant; W Conrad Hong; Amy H Newman; Lei Shi
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

2.  Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

3.  The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands.

Authors:  Ashish K Mishra; Timur Mavlyutov; Deo R Singh; Gabriel Biener; Jay Yang; Julie A Oliver; Arnold Ruoho; Valerică Raicu
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

4.  Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

Review 5.  Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives.

Authors:  Francesca Serena Abatematteo; Mauro Niso; Marialessandra Contino; Marcello Leopoldo; Carmen Abate
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

6.  Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor.

Authors:  Víctor Fernández-Dueñas; Javier Burgueño; Francisco Ciruela
Journal:  Front Pharmacol       Date:  2017-01-17       Impact factor: 5.810

Review 7.  The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD).

Authors:  Kai Yang; Changcai Wang; Taolei Sun
Journal:  Front Pharmacol       Date:  2019-05-21       Impact factor: 5.810

Review 8.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.